Application of photo-crosslinking agent in living cell and tissue sample protein conformation and interaction network analysis

The crosslinking reaction caused by light induced in living cells and tissue samples was solved by the photocrosslinking agent, and the problems of insufficient permeability of cell membranes and long reaction time in the prior art were solved, and a high-resolution protein conformation and interaction network were achieved. Information capture provides important insights into disease state and physiological properties.

CN118980756APending Publication Date: 2024-11-19CHINA PHARM UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411053442.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-02
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

The existing chemical crosslinking mass spectrometry technology has problems such as insufficient permeability of cell membranes, long reaction time and limited structural information in protein conformation and interaction network analysis in living cells and tissue samples, and it is difficult to capture the transient dynamic conformation of proteins.

Method used

Using a photocrosslinking agent, it reacts with proteins instantaneously through light irradiation, and has cell membrane permeability. It is used for protein conformation and interaction network analysis in living cells and tissue samples, including the selection of DCD and DSGD as representative photocrosslinking agents , combined with laser irradiation and pretreatment technology, improve crosslinking efficiency and product quantity.

Benefits of technology

High-resolution protein conformation and interaction network information capture in living cells and tissue samples is achieved, providing protein transient conformation and interaction information, enhancing the understanding of disease state and physiological characteristics, and being universal and efficient.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118980756A_ABST
    Figure CN118980756A_ABST
Patent Text Reader

Abstract

The invention discloses an application of a photo-crosslinking agent in living cell and tissue sample protein conformation and interaction network analysis. The photo-crosslinking agent can be used for living cell and / or tissue sample protein conformation analysis and protein interaction network analysis, the general formula of the photo-crosslinking agent is # imgabs0 #, and n is an integer selected from 1-6. The photo-crosslinking agent can be instantly activated in illumination, can be applied to living cell and tissue samples, and directly obtains protein conformation and protein interaction network information from the living cell and tissue samples.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology, and particularly relates to the application of a photocrosslinker in the analysis of protein conformation and interaction network of living cells and tissue samples. Background Art

[0002] The dynamics of target proteins in living cells will form "transient" or "unpredictable" drug binding pockets or key transient conformations, and this property is crucial for drug design. Therefore, real-time monitoring and analysis of dynamic conformational changes of target proteins in living cells can provide key biological information for new drug research and development, help optimize drug design and predict drug activity, and accelerate the process of new drug research and development. In disease states, the expression level, conformation, and interaction network of proteins in the body will change. Currently, protein conformations and protein interaction networks in disease states can be analyzed in cell models, but there are still some diseases that cannot be analyzed using cell models, which limits in-depth research on these diseases. Therefore, directly obtaining protein structural characteristics and interaction network information at the living cell level and tissue samples plays an important role in the analysis of disease pathogenesis, drug target screening, and new drug development.

[0003] Conventional structural biology techniques such as X-ray crystallography, nuclear magnetic resonance spectroscopy, and cryo-electron microscopy can provide high-resolution structural information. However, the above methods still have limitations, such as high requirements for sample purity and sample quantity, restrictions on the molecular weight of the protein to be tested, or the need to crystallize the protein or protein complex. Structural prediction technology based on AI algorithms has not yet been able to accurately predict the dynamic changes in protein structure. Although other technologies such as fluorescence resonance energy transfer and electron paramagnetic resonance can detect protein changes or interactions in solution, they require protein labeling and have limited detection throughput. At the same time, the above technologies cannot be directly applied to the analysis of living cells or tissue samples, which limits their application in the dynamic analysis of protein structure and interaction networks.

[0004] Chemical cross-linking mass spectrometry can obtain information on protein conformation and protein-protein interactions. It has been widely used in the fields of protein structure and interaction network analysis due to its advantages such as fast detection speed, low sample requirement, and strong biocompatibility. This technology introduces chemical cross-linking agents with active groups at both ends to connect two amino acids that are close enough in space in the form of covalent bonds. After enzymatic hydrolysis and other steps, the cross-linking products and cross-linking sites are identified by mass spectrometry. Combined with the maximum arm length limit of the cross-linking agent and molecular dynamics, protein conformation can be simulated and reshaped, providing spatial distance information for the analysis of protein conformation and interaction network.

[0005] However, currently only a few cross-linking agents are cell membrane permeable and can be used for analysis at the living cell level, but they are limited by the specificity of the cross-linking agent reaction sites and provide limited structural information. At the same time, the long cross-linking reaction time is not conducive to capturing the transient dynamic conformation of proteins, which makes the chemical cross-linking mass spectrometry technology slow in the analysis of protein dynamic conformation. In addition, the application of chemical cross-linking mass spectrometry technology in the analysis of protein structure and interaction network at the tissue level is still limited. Summary of the invention

[0006] Purpose of the invention: The purpose of the present invention is to provide an application of a photocrosslinker in the analysis of protein conformation and interaction network of living cells and tissue samples. The photocrosslinker of the present invention can undergo a crosslinking reaction with proteins at the moment of illumination, has cell membrane permeability, and can be used to capture protein conformation and protein interaction network information in living cells and tissue samples, thereby being used for the analysis of protein conformation and protein interaction network of living cells and tissue samples.

[0007] Technical solution: The purpose of the present invention is achieved through the following technical solution:

[0008] The present invention provides an application of a photocrosslinker in the analysis of protein conformation in living cells and / or tissue samples, wherein the general formula of the photocrosslinker is:

[0009]

[0010] Wherein, n is selected from an integer of 1-6.

[0011] The present invention also provides an application of the above-mentioned photocrosslinking agent in the analysis of protein interaction networks of living cells and / or tissue samples.

[0012] The above-mentioned photocrosslinkers of the general formula of the present invention can be used for analyzing the conformation and interaction network of proteins in living cells and / or tissue samples. The present invention selects photocrosslinkers DCD and DSGD as representatives for experimental verification.

[0013] The photocrosslinking agent is selected from:

[0014]

[0015] In a preferred embodiment of the present invention, the photocrosslinker is used in the analysis of protein conformation and interaction network of living cells and / or tissue samples. The photocrosslinker is dissolved in a solvent, incubated with pretreated living cells or tissue samples, and a crosslinking reaction occurs after laser irradiation.

[0016] Furthermore, the living cells are pretreated by blowing off the cells after trypsin digestion, centrifuging at 800 g for 5 minutes to obtain a cell pellet, and then incubating with a photocrosslinker.

[0017] The living cells described in the present invention take HeLa cells or 293T cells as examples.

[0018] Specifically, in order to obtain HeLa cells / 293T cell precipitates, HeLa cells / 293T cells were digested with trypsin, the trypsin was discarded, the digestion was terminated using a culture medium containing 10% fetal bovine serum, the cells in the culture dish were blown off, aspirated into a centrifuge tube, centrifuged at 800g for 5 minutes, and the supernatant was discarded to obtain a cell precipitate.

[0019] In order to achieve in situ crosslinking of the photocrosslinker in the tissue sample, it is further preferred that the tissue sample is pretreated by cutting the tissue sample into pieces of 1-2 mm. 3 Or the tissue sample is ground and homogenized and then incubated with a photocrosslinker.

[0020] In order to allow the photocrosslinker to fully enter the cells and improve the crosslinking efficiency and the number of crosslinked products, it is further preferred that the living cells are incubated by shaking the photocrosslinker and the living cells at 37° C. at 60 rpm for 10 minutes.

[0021] In order to allow the photocrosslinker to fully enter the tissue and improve the crosslinking efficiency and the amount of crosslinked products, it is further preferred that the tissue sample is incubated in a shaker at 37° C. and 60 rpm for 1 hour.

[0022] Further preferably, the solvent is selected from PBS solution.

[0023] In order to maximize the cross-linking efficiency, more preferably, the concentration of the photo-crosslinking agent in the PBS solution is 2-10 mM, which is the maximum concentration of different photo-crosslinking agents dissolved in the PBS solution.

[0024] In order to maximize the cross-linking efficiency, further, the concentration of the photocrosslinker DCD in the PBS solution was 2 mM, and the concentration of the photocrosslinker DSGD in the PBS solution was 10 mM.

[0025] In order to capture the transient conformation of proteins and the transient interaction between proteins, it is further preferred to perform laser irradiation after incubation of living cells or tissue samples with the photocrosslinker to activate the crosslinking reaction.

[0026] In order to ensure the cross-linking efficiency and laser uniformity, it is further preferred that the laser irradiation time of the living cell sample is 5 minutes, the laser irradiation time of the tissue sample is 3-5 minutes, and the wavelength of the laser is 355 nm.

[0027] The present invention also provides a method for analyzing living cell level or tissue sample, comprising the following steps:

[0028] (1) Pre-treating living cells or tissue samples;

[0029] (2) dissolving the photocrosslinker in a PBS solution and incubating the solution with the living cells or tissue samples pretreated in step (1);

[0030] (3) After incubation, laser irradiation is performed to activate the cross-linking reaction;

[0031] (4) Performing conventional proteomics pre-processing on the sample after the cross-linking reaction in step (3) and analyzing the cross-linking product.

[0032] In step (1), the pretreatment method of the living cells is to blow off the cells after trypsin digestion and centrifuge at 800g for 5 minutes to obtain a cell pellet;

[0033] In step (1), the tissue sample is pre-processed by cutting the tissue sample into pieces of 1-2 mm. 3 Or grinding and homogenization of tissue samples;

[0034] In step (2), the living cells are incubated by mixing the photocrosslinker with the living cells in a shaker at 37°C at 60 rpm, with inversion for 10 min;

[0035] In step (2), the tissue sample is incubated by incubating the photocrosslinker and the tissue sample in a shaker at 37°C and 60 rpm for 1 h;

[0036] In step (3), the laser irradiation time of the living cell sample is 5 minutes, the laser irradiation time of the tissue sample is 3-5 minutes, and the wavelength of the laser is 355nm.

[0037] The analysis method of the present invention can obtain protein instantaneous conformation information and protein interaction information at the living cell level, and can capture protein conformation and protein interaction network information in tissue fragments or homogenates, which is of great significance for understanding disease states and physiological characteristics that cannot be reproduced in cell culture models. The analysis method of the present invention adds cross-linking site information and achieves high-resolution structural analysis. It can be used for protein conformation and protein interaction network analysis of different cells or different tissue samples, and has universal applicability.

[0038] Beneficial effects:

[0039] (1) The photocrosslinker used in the present invention has no reaction selectivity to amino acid residues. Therefore, compared with the existing crosslinkers with reaction site restriction, the crosslinking site information is increased, and high-resolution structural analysis is achieved.

[0040] (2) The photocrosslinking agent used in the present invention can generate reporter ions of specific m / z during the secondary mass spectrometry fragmentation process, which can be used as a basis for judging the crosslinked products and help to quickly identify the crosslinked products in complex samples.

[0041] (3) The photocrosslinker used in the present invention has good cell membrane permeability, so protein transient conformation information and protein interaction information can be obtained at the living cell level.

[0042] (4) The photocrosslinker used in the present invention can enter tissue samples and capture protein conformation and protein interaction network information in tissue fragments or homogenates, which is of great significance for understanding disease states and physiological characteristics that cannot be replicated in cell culture models.

[0043] (5) The photocrosslinker used in the present invention can be used for protein conformation and protein interaction network analysis of different cells or different tissue samples, and has universal applicability. BRIEF DESCRIPTION OF THE DRAWINGS

[0044] Figure 1 The sites modified by photocrosslinker (DCD) and their effects on cell activity. Figure 1 A is the statistics of DCD modification sites based on cross-linking of HT22 cell lysate; Figure 1 B shows the MTT assay results of HeLa cells and 293T cells. Figure 2 The cross-linking results of HeLa cells and photocross-linker (DCD). Figure 2 A is the distribution diagram of HeLa cell cross-linking results. Figure 2 B is a statistical chart showing the proportion of cross-linked products in each organelle. Figure 2 C is the total number of cross-linked products and the number of cross-linked products between proteins, Figure 2 D is the number of new protein intermolecular cross-linking products that have been verified in the database and have not been reported; Figure 2 E is the 3D and 2D mapping of the results of cross-linking 39S ribosomes with a photocrosslinker (DCD). Figure 2 F is the 3D and 2D mapping results of 80S ribosome cross-linking using a photocrosslinker (DCD).

[0045] Figure 3 The results are shown for cross-linking of 293T cells with a photocross-linker (DCD). Figure 3 A is the distribution diagram of 293T cell cross-linking results. Figure 3 B is a statistical chart showing the proportion of cross-linking results in each organelle. Figure 3 C is the total number of cross-linked products and the number of cross-linked products between proteins, Figure 3 D is the number of new protein intermolecular cross-linking products that have been verified in the database and have not been reported; Figure 3 E is the 3D and 2D mapping of the results of cross-linking 39S ribosomes with a photocrosslinker (DCD). Figure 3 F is the 3D and 2D mapping results of 80S ribosome cross-linking with a photocrosslinker (DCD).

[0046] Figure 4The figure is a cross-linking result diagram obtained by identifying and screening the cross-linked products after the mouse heart tissue samples were treated in different ways and cross-linked with the photocross-linking agent (DCD); wherein, Figure 4 A is the cross-linking network diagram of the five complexes of Complex I-Complex V in the respiratory chain obtained by cross-linking after tissue grinding and treatment, and the cross-linking network diagram between the complexes. Figure 4 B is the cross-linking network diagram of the five complexes of Complex I-Complex V in the respiratory chain and the cross-linking network between the complexes after tissue shearing. Figure 4 C is the three-dimensional structural mapping of the cross-linking products between protein molecules within the respiratory chain Complex ⅠⅢ2Ⅳ supercomplex.

[0047] Figure 5 This is a cross-linking result diagram obtained after the mouse heart tissue sample was cross-linked with a photocross-linking agent (DSGD) and the cross-linking product was identified and screened; Figure 5 A shows the five complexes of Complex I-Complex V in the respiratory chain and the cross-linking network between the complexes. Figure 5 B is the three-dimensional structural mapping of the cross-linked products of protein molecules in the respiratory chain Complex I complex obtained after cross-linking with a photocrosslinker (DSGD). Figure 5 C is the three-dimensional structure mapping of the cross-linked product of protein molecules in the respiratory chain Complex Ⅳ obtained after cross-linking with a photocrosslinker (DSGD)

[0048] Figure 6 This is a diagram of the cross-linking results obtained after mouse liver tissue samples were cross-linked with a photocross-linker (DSGD) and then the cross-linked products were identified and screened.

[0049] Figure 7 This is a cross-linking result diagram obtained after the ileum tissue sample was cross-linked with a photocross-linking agent (DCD) and the cross-linking product was identified and screened; Figure 7 A is the protein interaction network related to ketone body metabolism pathway in the control purified diet group. Figure 7 B is the protein interaction network related to the ketone body metabolism pathway in the ketogenic diet group. DETAILED DESCRIPTION

[0050] The technical solution of the present invention is described in detail below through specific embodiments, but the protection scope of the present invention is not limited to the embodiments.

[0051] The experimental methods without specific conditions in the examples are usually carried out under conventional conditions or under conditions recommended by the raw material or product manufacturers. The reagents without specific sources are conventional reagents purchased from the market.

[0052] The enzymatic products after photocrosslinking were separated by Easy-nLC 1200 (Thermo Scientific) liquid phase system. The chromatographic column used was C18 column (Acclaim PepMapTM RSLC, 75μm×25cm); mobile phase A was water containing 0.1% formic acid, and mobile phase B was acetonitrile. The elution procedure was 3-8% B (2min), 8-28% B (4-67min), 28-38% B (67-80min), 38-100% B (80-84min), and finally maintained at 100% B (84-95min).

[0053] Orbitrap Eclipse Tribrid mass spectrometer was used to detect cross-linking products.

[0054] The parameters and model of the laser instrument used are: wavelength: 355nm, LWUVL355-120μJ.

[0055] Example 1 Preparation of Photocrosslinking Agent DCD

[0056] N 1 ,N 8 Synthesis of Bis(2-(3-methyl-3H-diazin-3-yl)ethyl)octanediamide

[0057]

[0058] Disuccinimidyl suberate (736mg, 2.0mmol) and 3-methyl-3H-bis-aziridine-3-ethylamine (416mg, 4.2mmol) are dissolved in dichloromethane (20mL), then triethylamine (1011.9mg, 10mmol) is added dropwise and stirred at room temperature for 18 hours. The mixture is washed with saturated ammonium chloride and saturated sodium bicarbonate, extracted with dichloromethane, and organic phase is collected and dried over anhydrous sodium sulfate. The solvent is removed under reduced pressure to obtain a crude product, and the crude product is purified by using methyl tert-butyl ether to make pulp to obtain the final product (477mg, yield 71%) of a white solid.

[0059] 1 HNMR (300MHz, CDCl3) δ (ppm) 5.97 (s, 1H), 3.18-3.11 (q, 4H), 2.19-2.14 (t, 4H), 1.64-1.55 (m, 8H), 1.35-1.30 (m, 4H), 1.03 (s, 6H).

[0060] 13CNMR (75MHz, CDCl3) δ (ppm) 173.22, 36.46, 34.59, 34.13, 28.73, 25.41, 24.54, 19.78.

[0061] Example 2 Preparation of photocrosslinking agent DSGD

[0062] N 1 , N 5 Synthesis of Bis(2-(3-methyl-3H-diazin-3-yl)ethyl)glutaramide

[0063]

[0064] Disuccinimidyl glutarate (400mg, 1.2mmol) and 3-methyl-3H-bis-aziridine-3-ethylamine (267mg, 2.7mmol) were dissolved in dichloromethane (10mL), and triethylamine (622mg, 6.2mmol) was then added dropwise and stirred at room temperature for 18 hours. The mixture was washed with saturated ammonium chloride and saturated sodium bicarbonate, extracted with dichloromethane, and the organic phase was collected and dried over anhydrous sodium sulfate. The solvent was removed under reduced pressure to obtain a crude product, which was purified by using methyl tert-butyl ether to obtain the final product (223mg, 63% yield) of a white solid.

[0065] 1 H NMR (300MHz, CDCl3) δ (ppm): 6.28 (s, 1H), 3.21-3.14 (q, 4H), 2.29-2.24 (t, 4H), 2.00-1.95 (m, 2H), 1.62-1.58 (m, 4H), 1.05 (s, 6H) 13 C NMR (75MHz, CDCl3) δ (ppm): 172.75, 35.26, 34.67, 34.06, 24.68, 21.79, 19.70.

[0066] Example 3 DCD cross-linker analyzes protein conformation and protein cross-linking network information in living cells

[0067] HT22 cells were cultured in a cell culture incubator at 37°C and 5% CO2 using DMEM medium containing 10% fetal bovine serum. HT22 cells were lysed on ice by sonication to obtain HT22 cell lysate, which was then centrifuged at 13,000 g for 10 minutes to remove cell debris. A PBS solution of DCD (2 mM) was mixed with the HT22 cell lysate, transferred to a light-proof glass insert, and irradiated with a 355 nm laser for 60 seconds after pouring liquid nitrogen. After protein purification, denaturation, enzymatic hydrolysis, and desalting, the cross-linked products were detected by OrbitrapEclipse Tribrid mass spectrometry. The results were used to determine the coverage and bias of the cross-linking sites. The obtained cross-linking data were identified by PEAKS Studio, and a variable DCD modification (+280.22 Da) was set. From the results, 114 proteins with a sequence coverage of ≥50% were screened, 754 modification sites were identified, and each peptide secondary spectrum was manually checked for the presence of a reporter ion m / z 281.22. The results showed that the DCD cross-linking sites can cover all amino acids and have a reaction preference for aspartic acid (D) and glutamic acid (E), e.g. Figure 1 As shown in A.

[0068] Taking HeLa and 293T cells as examples, the photocrosslinker DCD was applied to live cell crosslinking. HeLa cells were cultured in a cell culture incubator at 37°C and 5% CO2 using a HeLa cell-specific culture medium (containing 10% fetal bovine serum, 1% penicillin, and 1% streptomycin). 293T cells were cultured in a cell culture incubator at 37°C and 5% CO2 using DMEM culture medium containing 10% fetal bovine serum, 1% penicillin, and 1% streptomycin.

[0069] The MTT experiment was used to investigate the effect of DCD on the activity of HeLa / 293T cells. Serum-free MEM / DMEM medium containing a final concentration of 2mM DCD was added to Hela / 293T cells in normal growth state and incubated at 37°C for 10 minutes. The control group used HeLa / 293T cells of the same generation and culture time and culture conditions and the same growth state, and incubated for 10 minutes using the same volume of medium without DCD under the same conditions. MTT mother solution with a concentration of 5μg / μL was prepared with PBS. After the incubation, the culture medium in the two groups was discarded, and 100μL of MEM / DMEM culture medium and 10μL of MTT solution were added to each well. The 96-well plate was placed in a cell culture incubator and incubated for 4h. The culture medium in the 96-well plate was discarded, and 100μL of DMSO was added to each well at 37°C, 65rpm, for 15min. After the reaction, the absorbance was measured at a wavelength of 570nm. The results are shown in Figure 1 B, There was no significant difference after t-test, and the results showed that DCD had no effect on the activity of HeLa / 293T cells under the above experimental conditions.

[0070] After the HeLa cells / 293T cells were digested with trypsin, the trypsin was discarded, and the digestion was terminated with a medium containing 10% fetal bovine serum. The cells were blown off, centrifuged at 800g for 5 minutes, and the supernatant was discarded. The cell pellet was washed once with ice PBS and discarded to obtain a cell pellet. A 50mM DCD mother solution was prepared with DMSO, and DCD was diluted to 2mM with PBS containing 1× protease inhibitor (obtained by diluting 50× protease inhibitor with PBS) and phosphatase inhibitor (50× protease inhibitor and phosphatase inhibitor purchased from Biyuntian Biotechnology Co., Ltd.), 300μL was added to the cell pellet and gently blown, and the shaker was inverted at 37°C 60rpm for 10 minutes, and the supernatant containing DCD was discarded after quick shaking, and 300μL of PBS containing 1× protease inhibitor and phosphatase inhibitor was added to the cell pellet, and gently blown, and transferred to a light-proof glass inner tube, and irradiated with a 355nm laser for 5 minutes. The cross-linked cells were lysed, protein purified, denatured, enzymatically hydrolyzed, and desalted, and the cross-linked products were detected by Orbitrap Eclipse Tribrid mass spectrometry. The cross-linked peptides and cross-linking results were identified by xiSEARCH (version 1.7.6.7). The parameters of xiSEARCH were set as follows: the error range of the primary precursor ion and the secondary fragment ion was 10 ppm, Trypsin was selected as the enzyme setting, the fixed modification was set to: Carbamidomethylation (C), the variable modification was set to: Oxidation (M), the minimum number of amino acids in the peptide was 6, the maximum peptide mass was 5000, the maximum values ​​of PSM max FDR, peptide pair max FDR, residue pairs max FDR and protein pairs max FDR were all set to 5, and the boost was selected as residue pairs. The cross-linking sites were divided into six groups: EDAST, EDFQM, EDINK, EDPHC, EDRWL and EDVYG. The database is divided into 9 groups based on organelles, all of which were downloaded from Uniprot, with the species set to Human and the Status selected as Reviewed.

[0071] In the cross-linking results obtained, DCD captured a total of 1900 cross-linking products in HeLa cells, covering 1748 proteins; in 293T cells, DCD captured a total of 2278 cross-linking products, covering 2116 proteins, such as Figure 2 A. Figure 3 As shown in A, the cross-linked proteins are evenly distributed in nine organelles, such as Figure 2 B. Figure 3As shown in B. This indicates that DCD is widely distributed in cells, capturing protein conformations and protein interactions. In addition, the cross-linking products between protein molecules account for a high proportion in the cross-linking results, such as Figure 2 C, Figure 3 C. Among them, 133 pairs of protein cross-linking products in the HeLa cell cross-linking results and 167 pairs of protein cross-linking products in the 293T cell cross-linking results have been authenticated in the STRING, IntAct and BioGRID databases, as shown in Figure 2. Figure 2 D, Figure 3 D.

[0072] On this basis, the 39S ribosome (PDB: 7OIB, containing 49 proteins) and 80S ribosome (PDB: 4V6X, containing 82 proteins) complexes were analyzed as examples. The databases of the above two complexes were downloaded from Uniprot. In the HeLa cell cross-linking results, 57 cross-linking products were detected for the 39S ribosome, covering 24 proteins, and 38 cross-linking products were detected for the 80S ribosome, covering 30 proteins. Figure 2 E. Figure 2 As shown in F; in the 293T cell cross-linking results, 53 cross-linking products were detected for 39S ribosomes, covering 49 proteins, and 17 cross-linking products were detected for 80S ribosomes, covering 24 proteins. Figure 3 E. Figure 3 As shown in F.

[0073] These results indicate that photocrosslinkers applied in living cells can obtain protein conformational information and capture weak or transient protein interactions in their native state.

[0074] Example 4 DCD crosslinker to obtain respiratory chain crosslinking network of cardiac tissue homogenate sample

[0075] The 14-week-old C57BL / 6J mouse heart tissue samples used in this experiment were provided by the research group of Professor Wang Hong from China Pharmaceutical University. The mouse heart tissue samples were ground by adding PBS solution to obtain tissue grinding homogenate, and the PBS solution of photocrosslinker DCD (2mM final concentration) was mixed with the tissue homogenate, and incubated at 37℃ shaker at 60rpm for 1h, then irradiated with 355nm laser for 5min, and after proteomic sample processing (tissue sample lysis, protein purification, denaturation, enzymatic hydrolysis, desalting), the cross-linked products were detected by Orbitrap Eclipse Tribrid mass spectrometry, and the cross-linked peptides and cross-linking results were identified by xiSEARCH (version 1.7.6.7).

[0076] Taking the mitochondrial respiratory chain complex as an example, the database uses mitochondrial respiratory chain-related proteins. The database was downloaded from Uniprot, the species was set to Mouse, the Status was selected as Reviewed, and the parameters of xiSEARCH were set as follows: the error range of the primary precursor ion and the secondary fragment ion was 10 ppm, the enzyme setting selected Trypsin, the fixed modification was set to Carbamidomethylation (C), the variable modification was set to Oxidation (M), DCD-280, the minimum number of amino acids in the peptide was 6, the maximum peptide mass was 5000, the maximum values ​​of PSM max FDR, Peptide pair max FDR, Residue pairs max FDR and Protein pairs max FDR were all set to 5, boost was selected as Residue pairs, the amino acid site was set to X, and the reporter ion m / z was manually screened. The cross-linked products of 281.21 can be used to obtain the cross-linked network of respiratory chain-related proteins in heart tissue at the homogenate level. A total of 64 cross-linked products were obtained, covering 47 proteins, including 22 intra-subunit cross-linked products, 42 cross-linked products between different subunits, and 9 cross-linked products between complexes. The results are as follows Figure 4 As shown in A.

[0077] Example 5 DCD crosslinker to obtain respiratory chain crosslinking network of heart tissue shredded samples

[0078] The 10-week-old Balb / c mouse heart tissue samples used in this experiment were provided by Professor Hao Haiping's research group at China Pharmaceutical University. The mouse heart tissue samples were cut into small pieces to obtain 1-2 mm 3 The photocrosslinker DCD in PBS (2 mM final concentration) was mixed with the tissue samples and incubated at 37 °C on a shaker at 60 rpm for 1 h. The samples were then irradiated with a 355 nm laser for 5 min. After proteomic sample processing, the crosslinked products were detected by Orbitrap Eclipse Tribrid mass spectrometry, and the crosslinked peptides and crosslinking results were identified by xiSEARCH (version 1.7.6.7).

[0079] Taking the mitochondrial respiratory chain complex as an example, the database uses mitochondrial respiratory chain related proteins, and the parameter settings of xiSEARCH are the same as those in Example 4. A cross-linking network of respiratory chain related proteins in heart tissue after treatment before shearing is obtained. A total of 90 cross-linking products are obtained, covering 56 proteins, including 25 intra-subunit cross-linking products, 65 cross-linking products between different subunits, and 7 cross-linking products between complexes. The results are as follows Figure 4 As shown in B.

[0080] The cross-linking information obtained by DCD was further applied to the analysis of the assembly process of the respiratory chain supercomplex. The database used was a database formed by combining Complex I, Complex III2, and Complex IV in pairs to obtain as much cross-linking information between complexes as possible. A total of 10 cross-links between complexes were obtained, such as Figure 4 As shown in Figure C, 9 cross-linking products are cross-links between Complex I and Complex III2 and Complex IV. The cross-linking results are cross-links between different assembly modules of Complex I and Complex III2 and Complex IV, involving PP-b module, Qmodule and N module. This is consistent with the fact that Complex I begins to participate in the assembly of the supercomplex during the assembly stage. Among them, Ndufv1 and Ndufs4 are components of the peripheral arm N-module, which are crucial to the final step of Complex I assembly. The results show cross-links between these two subunits and Complex III2, Ndufs4(S116)-Uqcrfs1(E161) and Ndufv1(D390)-Uqcrfs1(A166).

[0081] The results of Example 4 and Example 5 show that the photocrosslinker is compatible with different tissue pretreatment methods, and the protein interaction information in the tissue can be obtained by shearing and grinding and homogenization.

[0082] Example 6 DSGD cross-linker to obtain respiratory chain cross-linking network of cardiac tissue fragment samples

[0083] The 14-week-old C57 mouse heart tissue samples used in this experiment were provided by Professor Wang Hong's research group at China Pharmaceutical University. The mouse heart tissue samples were cut into pieces to obtain 1-2 mm 3 Heart tissue fragments of different sizes were mixed with a PBS solution of the photocrosslinker DSGD (final concentration of 10 mM) and treated under the same experimental conditions as in Example 5. The xiSEARCH parameters were set as follows: variable modification was set to: Oxidation (M), DSGD-238, and other parameter settings were the same as those for DCD crosslinking data identification. By manually screening the reporter ion m / z 239.169, a crosslinking network of respiratory chain-related proteins in heart tissue was obtained. A total of 126 crosslinking products were obtained, covering 58 proteins, including 45 intra-subunit crosslinking products, 81 crosslinking products between different subunits, and 5 crosslinking products between complexes. The results are shown in Figure 2. Figure 5 As shown in A.

[0084] The cross-linking information obtained by the photocrosslinker DSGD was further applied to the analysis of the specific respiratory chain complex assembly process. Taking the mitochondrial complexes Complex I and Complex IV as examples, the database used Complex I and Complex IV related proteins, and the other xiSEARCH parameter settings were the same as above, and the protein interaction information within the complexes of the mouse heart tissue respiratory chain Complex I and Complex IV was obtained. In the cross-linking results obtained, there are 6 cross-linked products in Complex I that cross the mitochondrial inner membrane, such as Figure 5 As shown in B, it shows that the photocrosslinker has good cell membrane permeability at the tissue level and can pass through the inner membrane of mitochondria to capture crosslinking information. The crosslinking results of Complex IV include crosslinking between Cox5b and Cox6c: Cox5b(P60)-Cox6c(Y50), and crosslinking between Cox6b1 and mt-Co3: Cox6b1(W31)-mt-Co3(F227), as shown in Figure 5 As shown in Figure C, this is consistent with the formation of the second and third assembly modules (MT-CO2 module and MT-CO3 module) during the assembly process of Complex IV.

[0085] In addition to obtaining information about protein interactions, cross-linking results can also be used to analyze protein conformation in tissue samples. The database uses ComplexⅡ-related proteins, and the other xiSEARCH parameter settings are the same as above. In the cross-linking results within the ComplexⅡ complex obtained by DSGD, DSGD captured the cross-linking products within the four SDHB subunit molecules. Table 1 shows the cross-linking sites within the SDHB protein molecule obtained by DSGD. This shows that photocrosslinkers can be used to analyze protein conformation.

[0086] Table 1 DSGD obtained SDHB protein intramolecular cross-linking sites

[0087]

[0088] Combined with the complex cross-linking information obtained by the photocrosslinker DCD used in Example 5, taking the cross-linking results within the Complex Ⅱ complex as an example, the results of the two photocrosslinkers complement each other, as shown in Table 2, providing more cross-linking information within the Complex Ⅱ protein, indicating that photocrosslinkers with different arm lengths can provide complementary structural and complex information.

[0089] Table 2 Results of intra-protein cross-linking of Complex II obtained by DCD and DSGD

[0090]

[0091] Example 7 DSGD obtains liver tissue protein interaction cross-linking network

[0092] The liver tissue samples of 24-26 week old C57 mice used in this experiment were provided by Professor Zheng Xiao's research group at China Pharmaceutical University. 3 Tissue fragments of different sizes were mixed with a PBS solution of the photocrosslinker DSGD (final concentration of 10 mM). The experimental conditions were the same as those in Example 6. The proteins obtained by mass spectrometry data identification using PEAKS Studio were used as a database, which contained a total of 2472 proteins. The crosslinked products were further identified using xiSEARCH. The remaining xiSEARCH parameter settings were the same as those in Example 6. The protein interaction network in the liver tissue sample was obtained by identifying the crosslinked products and manually screening the reporter ion m / z239.169. Figure 6 As shown, there are 134 cross-linked products covering 202 proteins, of which 133 are cross-linked products between different proteins. The above results indicate that the photocrosslinker used can be used for protein conformation and protein interaction network analysis in different tissues.

[0093] Example 8 DCD cross-linker to obtain protein cross-linked network of ileum tissue homogenate sample

[0094] The C57BL / 6J mouse ileum tissue samples used in this experiment were provided by the research group of Professor Zheng Xiao from China Pharmaceutical University. The control purified diet group was fed with the American AIN-93 standard feed, and the ketogenic diet group was fed with the adult LCT ketogenic model feed TP201450, and the model was established for one week. The mouse ileum tissue samples (divided into the control purified diet group and the ketogenic diet group) were added to PBS for grinding and processing to obtain tissue grinding homogenate. The PBS solution of the photocrosslinker DCD (2mM final concentration) was mixed with the tissue homogenate and mixed at 400rpm for 10min at 37°C. After the protein group samples were processed, the cross-linked products were detected by Orbitrap Eclipse Tribrid mass spectrometry, and xiSEARCH (version 1.7.6.7) was used to identify the cross-linked peptides. The mouse ketone body metabolic pathway-related proteins were used as the database, and the rest of the settings were the same as in Example 4. Two different groups of protein interaction networks were obtained, such as Figure 7 As shown, Figure 7 A is the protein interaction network related to ketone body metabolism pathway in the control purified diet group. Figure 7 B is the protein interaction network related to the ketone body metabolism pathway in the ketogenic diet group, in which the proteins corresponding to the dark circles are proteins unique to the control group or the ketogenic diet group.

[0095] Among them, the interaction between Acat2 and Fasn was captured in the ketogenic diet group. The two genes are respectively involved in the biosynthesis pathway of cholesterol in the cytoplasm and catalyze the de novo biosynthesis of long-chain saturated fatty acids using acetyl-CoA and malonyl-CoA as raw materials. The two genes are co-expressed. This interaction information is consistent with the theory that the ketogenic diet group produces ATP through the tricarboxylic acid cycle and uses ketone bodies to produce fat or cholesterol; while there is no interaction information between the two proteins in the control group.

[0096] The above results indicate that photocrosslinkers can be used for differential analysis of protein interaction networks in living cells and different model tissues, which is of great significance for analyzing the functional differences of proteins under different physiological and pathological states.

[0097] As described above, although the present invention has been shown and described with reference to specific preferred embodiments, it should not be construed as limiting the present invention itself. Various changes in form and details may be made without departing from the spirit and scope of the present invention as defined in the appended claims.

Claims

1. Use of a photocrosslinker in protein conformation analysis of living cells and / or tissue samples, characterized in that: The general formula of the photocrosslinking agent is: Wherein, n is selected from an integer of 1-6.

2. Application of a photocrosslinker in the analysis of protein interaction networks in living cells and / or tissue samples, characterized in that: The general formula of the photocrosslinking agent is: Wherein, n is selected from an integer of 1-6.

3. The use according to claim 1 or 2, characterized in that: The photocrosslinking agent is selected from:

4. The use according to claim 1 or 2, characterized in that: The photocrosslinking agent is dissolved in a solvent and incubated with the pre-treated living cells or tissue samples, and a crosslinking reaction occurs after laser irradiation.

5. The use according to claim 4, characterized in that: The pretreatment method of the living cells is to blow off the cells after trypsin digestion, centrifuge at 800g for 5 minutes to obtain cell sediment, and then incubate with a photocrosslinker.

6. The use according to claim 4, characterized in that: The tissue sample is pre-processed by cutting it into pieces of 1-2 mm 3 Or the tissue sample is ground and homogenized and then incubated with a photocrosslinker.

7. The use according to claim 5 or 6, characterized in that: The living cells were incubated in a 37°C shaker at 60 rpm for 10 min, and the tissue samples were incubated in a 37°C shaker at 60 rpm for 1 h.

8. The use according to claim 4, characterized in that: The solvent is selected from PBS solution.

9. The use according to claim 8, characterized in that: The concentration of the photocrosslinking agent in the PBS solution is 2-10 mM, which is the maximum concentration of different photocrosslinking agents dissolved in the PBS solution.

10. The use according to claim 4, characterized in that: The laser irradiation time of the living cell sample is 5 minutes, the laser irradiation time of the tissue sample is 3-5 minutes, and the wavelength of the laser is 355nm.